A new second-generation supraglottic airway device (Ambu(®) AuraGain(•)) versus intubating laryngeal mask airway as conduits for blind intubation – A prospective, randomised trial

BACKGROUND AND AIMS: The Ambu(®) AuraGain(•) is a new single-use supraglottic airway device with gastric channel, designed to facilitate intubation. The study aimed to assess the success rates of proper placement and intubation using Ambu(®) AuraGain(•) compared with intubating laryngeal mask airway...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Indian J Anaesth
Autori principali: Sudheesh, K, Chethana, GM, Chaithali, H, Nethra, SS, Devikarani, D, Shwetha, G
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer - Medknow 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6644201/
https://ncbi.nlm.nih.gov/pubmed/31391619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ija.IJA_269_19
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi